Search tips
Search criteria 


Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
AAPS PharmSciTech. 2004 December; 5(4): 1–9.
Published online 2004 October 11. doi:  10.1208/pt050451
PMCID: PMC2750476

Biodegradable microspheres as carriers for native superoxide dismutase and catalase delivery


The purpose of this research was to encapsulate superoxide dismutase (SOD) and catalase (CAT) in biodegradable microspheres (MS) to obtain suitable sustained protein delivery. A modified water/oil/water double emulsion method was used for poly(D,L-lactide-co-glycolide) (PLGA) and poly(D,L-lactide) PLA MS preparation co-encapsulating mannitol, trehalose, and PEG400 for protein stabilization. Size, morphology, porosity, mass loss, mass balance, in vitro release and in vitro activity were assessed by using BCA protein assay, scanning electron microscopy, BET surface area, and particle-sizing techniques. In vitro activity retention within MS was evaluated by nicotinammide adenine dinucleotide oxidation and H2O2 consumption assays. SOD encapsulation efficiency resulted in 30% to 34% for PLAMS and up to 51% for PLGA MS, whereas CAT encapsulation was 34% and 45% for PLGA and PLAMS, respectively. All MS were spherical with a smooth surface and low porosity. Particle mean diameters ranged from 10 to 17 μm. CAT release was prolonged, but the results were incomplete for both PLA and PLGA MS, whereas SOD was completely released from PLGA MS in a sustained manner after 2 months. CAT results were less stable and showed a stronger interaction than SOD with the polymers. Mass loss and mass balance correlated well with the release profiles. SOD and CAT in vitro activity was preserved in all the preparations, and SOD was better stabilized in PLGA MS. PLGA MS can be useful for SOD delivery in its native form and is promising as a new depot system.

Keywords: superoxide dismutase, catalase, microspheres, protein delivery, in vitro activity

Full Text

The Full Text of this article is available as a PDF (770K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Control Release. 2003;90:261–280. doi: 10.1016/S0168-3659(03)00194-9. [PubMed] [Cross Ref]
2. DeLuca PP, Mehta RC, Hausberger AG, Thanoo BC. Biodegradable polyesters for drug and polypeptide delivery. ACS Symposium Series; 9. In: ELNokaly MA, Piatt DM, Charpentier BA, editors. Polymer Delivery Systems, Properties and Applications. Washington, DC: American Chemical Society; 1993. pp. 53–79.
3. Xinteng Z, Weisan P, Ruhua Z, Feng Z. Preparation and evaluation of poly (D,L-lactic acid) (PLA) or D,L-lactide/glycolide copolymer (PLGA) microspheres with estradiol. Pharmazie. 2002;57:695–697. [PubMed]
4. Zhou S, Liao X, Li X, Deng X, Li H. Poly-d,l-lactide-co-poly(ethylene glycol) microspheres as potential vaccine delivery systems. J Control Release. 2003;86:195–205. doi: 10.1016/S0168-3659(02)00423-6. [PubMed] [Cross Ref]
5. Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997;28:5–24. doi: 10.1016/S0169-409X(97)00048-3. [PubMed] [Cross Ref]
6. Dani BA, DeLuca PP. Preparation, characterization, and in vivo evaluation of salmon calcitonin microspheres. AAPS PharmSciTech. 2001;2(4):E22–E22. doi: 10.1208/pt020422. [PMC free article] [PubMed] [Cross Ref]
7. Weert M, Hennink WE, Jiskoot W. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm Res. 2000;17:1159–1167. doi: 10.1023/A:1026498209874. [PubMed] [Cross Ref]
8. Murty SB, Goodman J, Thanoo BC, DeLuca PP. Identification of chemically modified peptide from poly(lactic-co-glycolide) microspheres under in vitro release conditions. AAPS PharmSciTech. 2003;4(4):E50–E50. doi: 10.1208/pt040450. [PMC free article] [PubMed] [Cross Ref]
9. Castellanos IJ, Crespo R, Griebenow K. Poly(ethylene glycol) as stabilizer and emulsifying agent: a novel stabilization approach preventing aggregation and inactivation of proteins upon encapsulation in bioerodible polyester microspheres. J Control Release. 2003;88:135–145. doi: 10.1016/S0168-3659(02)00488-1. [PubMed] [Cross Ref]
10. Na DH, Murty SB, Lee KC, Thanoo BC, DeLuca PP. Preparation and stability of poly(ethylene glycol) (PEG)ylated ocreotide for application to microsphere delivery. AAPS PharmSciTech. 2003;4(4):E72–E72. doi: 10.1208/pt040472. [PMC free article] [PubMed] [Cross Ref]
11. Lam XM, Duenas ET, Cleland JL. Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres. J Pharm Sci. 2001;90:1356–1365. doi: 10.1002/jps.1088. [PubMed] [Cross Ref]
12. Capan Y, Jiang G, Giovagnoli S, Na KH, DeLuca PP. Preparation and characterization of poly(D,L-lactide-co-glycolide) microspheres for controlled release of human growth hormone. AAPS PharmSciTech. 2003;4(2):E28–E28. doi: 10.1208/pt040228. [PMC free article] [PubMed] [Cross Ref]
13. Mruka DD, Silvestrini B, Moa MY, Yan Chenga C. Antioxidant superoxide dismutase—a review: its function, regulation in the testis, and role in male fertility. Contraception. 2002;65:305–311. doi: 10.1016/S0010-7824(01)00320-1. [PubMed] [Cross Ref]
14. Peeters-Joris C, Vandevoorde A, Baudhuin P. Subcellular localization of superoxide dismutase in rat liver. Biochem J. 1975;150:31–39. [PubMed]
15. Tyler D D. Polarographic assay and intracellular distribution of superoxide dismutase in rat liver. Biochem J. 1975;147(3):493–504. [PubMed]
16. Winterbourn CC, Hawkins R, Brian M, Carrell R. The estimation of red cell superoxide dismutase activity. J Lab Clin Med. 1975;85(2):337–341. [PubMed]
17. Fita I, Rossmann M. The NADPH binding site on beef liver catalase. Proc Natl Acad Sci USA. 1985;82:1604–1608. doi: 10.1073/pnas.82.6.1604. [PubMed] [Cross Ref]
18. Kirkman H, Gaetani G. Catalase: A tetrameric enzyme with four tightly bound molecules of NADPH. Proc Natl Acad Sci USA. 1984;81:4243–4247. doi: 10.1073/pnas.81.14.4343. [PubMed] [Cross Ref]
19. Zhao X, Zhang T. Lyophilized and liposomal preparations of superoxide dismutase. Shandong Yike Daxue Xuebao. 1986;24:42–48.
20. Wagner A, Vorauer-Uhl K, Kreismayr G, Katinger H. Enhanced protein loading into liposomes by the multiple crossflow injection technique. J Liposome Res. 2002;12:271–283. doi: 10.1081/LPR-120014762. [PubMed] [Cross Ref]
21. Zhao J, Wang F, Zhou L, Yuan Q. Preparation of SOD (superoxide dismutase) liposomes by freeze-thaw method. Zhongguo Yiyao Gongye Zazhi. 2004;27(8):346–349.
22. Buckley BJ, Tanswell AK, Freeman BA. Liposome-mediated augmentation of catalase in alveolar type II cells protects against hydrogen peroxide injury. J Appl Physiol. 1987;63:359–367. [PubMed]
23. Walther FJ, David-Cu R, Supnet MC, Longo ML, Fan BR, Bruni R. Uptake of antioxidants in surfactant liposomes by cultured alveolar type II cells is enhanced by SP-A. Am J Physiol. 1993;265:L330–L339. [PubMed]
24. Corvo ML, Boerman OC, Oyen WJG, et al. Subcutaneous administration of superoxide dismutase entrapped in long circulating liposomes: in vivo fate and therapeutic activity in an inflammation model. Pharm Res. 2000;17:600–606. doi: 10.1023/A:1007577101964. [PubMed] [Cross Ref]
25. Bando K, Senoo Y, Noji M, Ootsuki K, Ekimoto Hi, Irie Y. Superoxide dismutase liposomes for prevention and remedy of injuries caused by ischemia. European Patents Application, 1989.
26. Nakae D, Yamamoto K, Yoshiji H, et al. Liposome-encapsulated superoxide dismutase prevents liver necrosis induced by acetaminophen. Am J Pathol. 1990;136:787–795. [PubMed]
27. Morita T, Sakamura Y, Horikiri Y, Suzuki T, Yoshino H. Protein encapsulation into biodegradable microspheres by a novel S/O/W emulsion method using poly(ethylene glycol) as a protein micronization adjuvant. J Control Release. 2000;69:435–444. doi: 10.1016/S0168-3659(00)00326-6. [PubMed] [Cross Ref]
28. Liu L, Yuan Q. Preparation and properties of superoxide dismutase poly(DL-lactide-co-glycolide acid) microspheres. Zhongguo Yiyao Gongye Zazhi. 2003;34:15–18.
29. Brown KE, Leong K, Huang CH. Gelatin/chondroitin 6-sulfate microspheres for the delivery of therapeutic proteins to the joint. Arthritis Rheum. 1998;41:2185–2195. doi: 10.1002/1529-0131(199812)41:12<2185::AID-ART13>3.0.CO;2-C. [PubMed] [Cross Ref]
30. Rosas JE, Hernandez RM, Gascon AR, et al. Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66. Vaccine. 2001;19:4445–4451. doi: 10.1016/S0264-410X(01)00192-X. [PubMed] [Cross Ref]
31. Shibuya T, Watanade Y, Nalley KA, Fusco A, Salafsky B. The BCA protein determination system: an analysis of several buffers, incubation temperature and protein standards. Tokyo Ika Daigaku Zasshi. 1989;47(4):677–682.
32. Paoletti F, Mocali A. Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation. Methods Enzymol. 1990;186:209–220. doi: 10.1016/0076-6879(90)86110-H. [PubMed] [Cross Ref]
33. Akgöl S, Kaçar Y, Özkara S, Yavuz H, Denizli A, Arica YM. Immobilization of catalase via adsorption onto 1-histidine grafted functional pHEMA based membrane. J Mol Catal, B Enzym. 2001;15:197–206. doi: 10.1016/S1381-1177(01)00029-7. [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists